Jacques Gonella, Director at ANTARES PHARMA, INC. (ATRS), sold 400,000 shares at $3.79 ($1.5M) on 2018-10-02, disclosed to the SEC on 2018-10-04.
Open-market sale of $1.5M ATRS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ATRS | SELL | 2018-08-10 | $1.5M | — | Filing → |
| ATRS | SELL | 2018-06-20 | $2K | — | Filing → |
| ATRS | SELL | 2018-06-13 | $546K | — | Filing → |